SFX by Ex Libris Inc.

Title:	In vivo release of DOPA and dopamine from genetically engineered cells grafted to the denervated rat striatum
Source:	Neuron [0896-6273] Horellou, Philippe yr:1990

Basic

Full text

Full text available via EZB-NALI5-00465 Elsevier Archive NL

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Wang Zhongfeng, Z. "Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons." Neuron 50.3 (2006): 443-452.
description	2.	Gainetdinov, Rui M M. "Rapid alterations in corticostriatal ensemble coordination during acute dopamine-dependent motor dysfunction." Neuron 52.2 (2006): 359-69.
description	3.	Breakefield, Y. "The pathophysiological basis of dystonias." Nature reviews. Neuroscience 9.3 (2008): 222-34.
description	4.	Niv, Y. "Tonic dopamine: opportunity costs and the control of response vigor." Psychopharmacology 191.3 (2007): 507-520.
description	5.	CULLCANDY, S. "Regulation of Ca2+-permeable AMPA receptors: synaptic plasticity and beyond." Current Opinion in Neurobiology 16.3 (2006): 288-97.
description	6.	Kreitzer, Anatol C C. "Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models." Nature 445.7128 (2007): 643-7.
description	7.	Greger, José A A. "AMPA receptor biogenesis and trafficking." Current Opinion in Neurobiology 17.3 (2007): 289-97.
description	8.	Cull-Candy, Stuart G G. "Role of distinct NMDA receptor subtypes at central synapses." Science's STKE 2004.255 (2004).
description	9.	Kristensen, Anders S S. "Glutamate receptors: variation in structure-function coupling." Trends in Pharmacological Sciences 27.2 (2006): 65-9.
description	10.	Hansen, Kasper B. "Structural aspects of AMPA receptor activation, desensitization and deactivation." Current Opinion in Neurobiology 17.3 (2007): 281-288.
description	11.	Collingridge, Graham L L. "Receptor trafficking and synaptic plasticity." Nature reviews. Neuroscience 5.12: 952-962.
description	12.	Geyer, Howard L L. "The diagnosis of dystonia." Lancet. Neurology 5.9 (2006): 780-90.
description	13.	Phukan, J. "Primary dystonia and dystonia-plus syndromes: clinical characteristics, diagnosis, and pathogenesis." Lancet neurology 10.12 (2011): 1074-1085.
description	14.	Birklein, F. "Autoimmunity in Complex-Regional Pain Syndrome." Annals of the New York Academy of Sciences 1107.1 (2007): 168-73.
description	15.	de Lau, Lonneke M. "Serum Cholesterol Levels and the Risk of Parkinson's Disease." American journal of epidemiology 164.10 (2006): 998-1002.
description	16.	Niv, Y. "A normative perspective on motivation." Trends in cognitive sciences 10.8 (2006): 375-381.
description	17.	Niv, Y. "Cost, benefit, tonic, phasic: what do response rates tell us about dopamine and motivation?" Annals of the New York Academy of Sciences 1104.1 (2007): 357-76.
description	18.	Leblois, A. "Late emergence of synchronized oscillatory activity in the pallidum during progressive parkinsonism." The European journal of neuroscience 26.6 (2007): 1701-1713.
description	19.	Patel, Steven S S. "Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism." Brain 129.7 (2006): 1732-47.
description	20.	Gatev, P. "Oscillations in the basal ganglia under normal conditions and in movement disorders." Movement disorders 21.10 (2006): 1566-1577.